AzTrials
AzTrials

Fear of FallingPhase 2NCT01609322

Exposure Therapy for Fear of Falling in Older Adults

A Phase 2 study testing Activity, Balance, Learning, and Exposure and Fall prevention education in people with Fear of Falling, run by University of California, San Diego at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project aims to test the efficacy of an in-home intervention, "Activity, Balance, Learning, and Exposure" (ABLE), which integrates exposure therapy with cognitive restructuring, exercise, and home safety evaluation for older adults with excessive fear of falling. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Fear of Falling
What is being tested?
Activity, Balance, Learning, and Exposure and Fall prevention education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
Aug 2010to Aug 2013
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Age 65 years old or older.
  • Severe fear as measured by a brief FES-I score > or = 13.
  • Low to moderate actual risk of falls as set out in Lamb et al. (2008).
  • Distress or functional impairment due to fear of falling.
  • Approval from the patient's primary health care provider.

Who cannot join

  • Medical condition that would interfere with the safe conduct of the intervention or compromise study participation.
  • Bedbound, wheelchair-dependent, paralyzed in the lower extremities, or requiring the assistance of another person to transfer, walk, or perform intervention exercises within the home.
  • Dementia or cognitive impairment as measured by a score above 10 on the Blessed Orientation Memory Test.
  • Corrected visual acuity < 20/60.
  • Current participation in psychotherapy or professional rehabilitation services (PT, OT) or in the process of being referred or evaluated for such services. Patients who develop a need for such services during their participation will complete an assessment prior to commencing the outside therapy but will be allowed to continue in the study.
  • Active suicidal ideation
Show all 13Show fewer
  • Lifetime diagnosis of bipolar I or II disorder or any psychotic disorder.
  • Alcohol or other substance abuse or dependence within six months.
  • Psychosocial factors that would compromise study participation (e.g. homelessness, no telephone).
  • History of osteoporotic fracture.
  • Experiencing 3 or more falls in the past year.
  • Body Mass Index of 17.0 or under.
  • Significant orthostasis, defined as a 20 point or greater difference between seated and standing blood pressure, either systolic or diastolic.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of California San Diego

    San Diego, California, 92103

Other trials in United States

About this study

This project aims to test the efficacy of an in-home intervention, "Activity, Balance, Learning, and Exposure" (ABLE), which integrates exposure therapy with cognitive restructuring, exercise, and home safety evaluation for older adults with excessive fear of falling. The intervention will be conducted by a licensed physical therapist. A control intervention will be conducted by a health educator. The specific aims of the study are to test the feasibility, acceptability, tolerability, and safety of the ABLE intervention.

Read the detailed description

Approximately 7-14% of older adults living independently in the community, including more than 5% of those who have never experienced a fall, experience moderate to severe fear of falling. Fear of falling leads to decreased physical activity, disability, loss of independence, depression, anxiety, reduced social engagement, and poor quality of life. It is also a major independent risk factor for falls.

Interventions targeting fear of falling, typically delivered in groups and incorporating cognitive restructuring, education, and exercise, have been shown to increase fall-related self-efficacy. Avoidance is resistant to treatment, however, and more than one-third of patients enrolled in these interventions drop out. Factors associated with attrition include high levels of fear and avoidance, indicating that the individuals most in need of such programs are those most likely to withdraw prematurely. These data suggest that avoidance should be targeted in treatment, and that interventions should be designed to reach very fearful individuals who are most likely to drop out of traditional fear of falling programs.

Participation in this study will last up to 8 months. Participants will be randomly assigned to receive either the ABLE intervention or an education control condition. The control condition will consist of in-person education about falls to control for the time and attention provided in the ABLE arm.

Conditions
Fear of Falling
Being tested
Activity, Balance, Learning, and Exposure, Fall prevention education
Keywords
fear of falling, agoraphobia
Medical subject headings
Agoraphobia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Activity, Balance, Learning, and ExposureBehavioural

    An in-home intervention that integrates exposure therapy with cognitive restructuring, exercise, and a home safety evaluation.

  • Fall prevention educationBehavioural

    In-home, individual sessions with a health educator regarding fall prevention

Study groups in NCT01609322
Study groupRoleWhat they receive
Education about fallsActive comparatorIn-person education about falls with a health educator.
Receives: Behavioral: Fall prevention education
Activity, Balance, Learning, and ExposureExperimentalIntervention combining medication review, exercise, home safety evaluation, and exposure therapy.
Receives: Behavioral: Activity, Balance, Learning, and Exposure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fear of falling

    Fear of Falling will be measured using the Falls Efficacy Scale - International (FES-I), a version of the most widely used measure of falls self-efficacy. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point). We will also collect data at 5 months (3 month follow-up) and 8 months (6 month follow-up).

    Measured: 2 months (primary)

  2. Activity avoidance

    Activity avoidance will be assessed using a modified version of the Activity Card Sort, a set of photographs of older adults engaged in various activities that is used in rehabilitation settings. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point), 5 months (3 month follow-up), and 8 months (6 month follow-up).

    Measured: 2 months (primary)

Secondary outcomes (10)
  1. Physical activity - self-report

    Self-reported physical activity will be assessed with the Physical Activities Scale for the Elderly (PASE).

    Measured: 2 months (primary)

  2. Physical activity

    Accelerometers will also be used to measure physical activity. Patients in the study will wear an Actigraph battery-operated activity monitor worn around the waist to measure physical activity continuously during waking hours. Assessment will occur before and after the intervention.

    Measured: 2 months

  3. Physical Performance

    Physical performance will be measured using the Short Physical Performance Battery (SPPB), which includes measured of balance, walking, and lower body strength.

    Measured: 2 months (primary)

  4. Quality of Life

    Quality of life will be measured with the Quality of Life Inventory (QOLI).

    Measured: 2 months (primary)

  5. Depressive and Anxiety symptoms

    Depressive and anxiety symptoms will be assessed with the Hospital Anxiety and Depression Scale (HADS), a 14-item self-report measure with subscales assessing depressive and anxiety symptoms that does not include somatic items such as fatigue that can be associated with aging or medical conditions rather than psychiatric disorders.

    Measured: 2 months (primary)

  6. Agoraphobic Avoidance

    Agoraphobic avoidance will be measured using the 5-item agoraphobia subscale of the Fear Questionaire (FQ).

    Measured: 2 months (primary)

  7. Post Traumatic Stress Disorder Symptoms

    Post Traumatic Stress Disorder (PTSD) symptoms will be measured with the 6-item abbreviated form of the PTSD Checklist (PCL).

    Measured: 2 months (primary)

  8. Fear of Falling

    Fear of falling will be measured using the Falling Questionaire, a 15-item survey assessing attitudes towards falling.

    Measured: 2 months (primary)

  9. Avoidance

    Avoidance of activities will be measured using the Fear of Falling Avoidance-Behavior Questionaire (FFABQ), a 14-item measure to assess avoidance behaviors.

    Measured: 2 months (primary)

  10. Falls

    Recorded on fall diaries provided to investigators throughout the 2-month intervention and 6-month follow-up period.

    Measured: 2 months (primary)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2012 (estimated)
  2. Study startAug 2010
  3. Primary completionAug 2013
  4. Study completionAug 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01609322
Sponsor's protocol ID
R34MH086668
Other IDs
R34MH086668
Status last verified
Dec 2013
First submitted
29 May 2012
Last updated
23 Dec 2013
Results posted
No
Data monitoring committee
Yes

Publications

  • Wetherell JL, Bower ES, Johnson K, Chang DG, Ward SR, Petkus AJ. Integrated Exposure Therapy and Exercise Reduces Fear of Falling and Avoidance in Older Adults: A Randomized Pilot Study. Am J Geriatr Psychiatry. 2018 Aug;26(8):849-859. doi: 10.1016/j.jagp.2018.04.001. Epub 2018 Apr 12.

    PubMed 29754811

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Activity, Balance, Learning, and Exposure and Fall prevention education in people with Fear of Falling, run by University of California, San Diego at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Dec 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fear of falling (time frame: 2 months (primary)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01609322, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in